Organigram (CVE: OGI) posted another strong revenue growth quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.
In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with operations. Impressive.
